WHITEBOX ADVISORS LLC 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-25 4:23 pm Sale |
2024-09-30 | 13G | Protalix BioTherapeutics, Inc. PLX |
WHITEBOX ADVISORS LLC | 0 0.000% |
-2,816,108 (Position Closed) |
Filing |
| 2022-06-09 2:52 pm Purchase |
2022-05-13 | 13G | Protalix BioTherapeutics, Inc. PLX |
WHITEBOX ADVISORS LLC | 2,816,108 5.650% |
2,816,108 (New Position) |
Filing |